Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial

Éric Baudin, Bernard Goichot, Alfredo Berruti, Julien Hadoux, Salma Moalla, Sandrine Laboureau, Svenja Nölting, Christelle de la Fouchardière, Tina Kienitz, Timo Deutschbein, Stefania Zovato, Laurence Amar, Magalie Haissaguerre, Henri Timmers, Patricia Niccoli, Antongiulio Faggiano, M. Angokai, Livia Lamartina, Florina Luca, Deborah Cosentini, Stefanie Hahner, Felix Beuschlein, Marie Attard, Matthieu Texier, Martin Faßnacht, Christine Do Cao, Delphine Drui, Françoise Borson‐Chazot, Olivier Chabre, Delphine Vezzosi, Frédéric Castinetti, Jérôme Bertherat, Rossella Libé, Anne‐Paule Gimenez‐Roqueplo, Judith Favier, Marcus Quinkler, Christian J. Strasburger, Katrin Zopf, Martín Reincke, Matthias Kroiß, Hanna Remde, Michaela Haaf, Carmina Teresa Fuß, Ulrich Dischinger, Graeme Eisenhofer, Christina Pamporaki, Anouk van Berkel